[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356866-105":59,"doc-detail-356866-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","shcbp1-is-upregulated-in-colon-adenocarcinoma-and-promotes-tumor-cell-proliferation-and-growth","SHCBP1 Is Upregulated in Colon Adenocarcinoma and Promotes Tumor Cell Proliferation and Growth","","Colon adenocarcinoma (COAD) presents high morbidity and mortality, making discovery of new therapeutic targets essential. This study examines SHC SH2-domain binding protein 1 (SHCBP1) in COAD using two complementary evidence streams: public-database analyses plus tissue-level and functional verification, together with exploratory in silico computations. SHCBP1 is markedly upregulated, linked to poor prognosis, and potentially driven by promoter hypomethylation. Bioinformatics associate SHCBP1 with DNA replication and cell-cycle pathways, while knockdown suppresses proliferation and tumor growth in vitro and in vivo. Network prediction and structure-based virtual screening prioritize candidate interactions and two compounds, requiring independent validation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/shcbp1-is-upregulated-in-colon-adenocarcinoma-and-promotes-tumor-cell-proliferation-and-growth/356866/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/shcbp1-is-upregulated-in-colon-adenocarcinoma-and-promotes-tumor-cell-proliferation-and-growth/356866.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main focus of the study regarding SHCBP1 in COAD?","Question",{"text":113,"@type":114},"The study evaluates whether SHCBP1 is upregulated in colon adenocarcinoma and whether it contributes to tumor cell proliferation and tumor growth. It combines database analyses with tissue validation and functional experiments.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is SHCBP1 expression linked to patient outcomes in the study?",{"text":118,"@type":114},"SHCBP1 is reported as significantly upregulated in COAD and associated with unfavorable prognosis. Promoter hypomethylation is suggested as a contributor to its increased expression.",{"name":120,"@type":111,"acceptedAnswer":121},"What do the in vitro and in vivo functional experiments show after SHCBP1 knockdown?",{"text":122,"@type":114},"SHCBP1 knockdown inhibits colon cancer cell proliferation and suppresses tumor growth in vivo. These results support a pro-tumor role for SHCBP1 in COAD.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356866,1790293353,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \nSHCBP1 Is Upregulated in Colon Adenocarcinoma and Promotes Tumor Cell Proliferation and Growth  \nYiren He 1,2,†, Qian Zhang 3,†, Xinyang He 3, * and Wenyong Wu 1,2, *  \nReceived: 4 March 2026  \nRevised: 27 April 2026  \nAccepted: 14 May 2026  \nPublished: 19 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 The Fifth Clinical Medical College, Anhui Medical University, No. 81, Meishan Road, Shushan District, Hefei 230032, China; [heyiren2007@yeah.net](heyiren2007@yeah.net)  \n2 Department of General Surgery, Anhui No. 2 Provincial People’s Hospital, Clinical College of Anhui Medical University, No. 1868, Dangshan Road, Yaohai District, Hefei 230011, China  \n3 Department of General Surgery, The Affiliated Provincial Hospital of Anhui Medical University, No. 17, Lujiang Road, Luyang District, Hefei 230001, China  \n* [Correspondence: hxy2333@126.com](Correspondence: hxy2333@126.com) (X.H.); [wwy_doc@163.com](wwy_doc@163.com) (W.W.)† These authors contributed equally to this work.  \nSimple Summary  \nColon adenocarcinoma (COAD) is a common and life-threatening malignancy, and new molecular targets are needed to improve treatment. In this study, we investigated SHCBP1 in COAD using public-database analyses, tissue-level validation, and functional experiments. SHCBP1 was highly expressed in tumor tissues and was associated with unfavorable prognosis. Functional experiments showed that SHCBP1 knockdown inhibited colon cancer cell proliferation and suppressed tumor growth in vivo. We also included exploratory computational analyses, including predicted interaction-network analysis and structurebased virtual screening, to generate hypotheses for future mechanistic and pharmacological studies. Overall, our findings support a role for SHCBP1 in COAD cell proliferation and tumor growth and provide a basis for further investigation.  \nAbstract  \nColon adenocarcinoma (COAD) is a common malignancy with substantial morbidity and mortality, and the identification of new therapeutic targets remains essential for improving patient outcomes. In this study, we investigated SHC SH2-domain binding protein 1 (SHCBP1) in COAD through two complementary components with distinct evidentiary scopes. The first component comprised expression profiling, prognostic and methylation analyzes, bioinformatic characterization, and functional validation in vitro and in vivo. The second component comprised exploratory computational analyses, including predicted interaction network analysis and structure-based virtual screening. Public databases were used to analyze SHCBP1 expression, prognosis, and promoter methylation status. Coexpression and functional enrichment analyses were performed to explore the biological context of SHCBP1 . In vitro and in vivo experiments were then conducted to evaluate the effects of SHCBP1 knockdown on tumor growth. SHCBP1 was significantly upregulated in COAD and was associated with poor patient prognosis. Promoter hypomethylation may contribute to its increased expression. Bioinformatic analyses suggested that SHCBP1 is associated with DNA replication and cell-cycle-related pathways. Experimental studies demonstrated that SHCBP1 knockdown suppressed cell proliferation and tumor growth. In the exploratory computational component, predicted interaction network analysis and virtual screening prioritized several in silico candidate interactions and two compounds with favorable predicted binding scores. These computational findings require independent biochemical and cellular validation. Overall, our findings suggest that SHCBP1 may  \nrepresent a candidate biomarker associated with COAD proliferation and unfavorable prognosis, as well as a putative molecular target that warrants further validation.  \nKeywords: COAD; SHCBP1; proliferation; biological function; virtual s","cbCairJmDYd2OqKO","https://ap.wps.com/l/cbCairJmDYd2OqKO","pdf",6577022,17,"English","# Introduction\n# SHCBP1 in COAD: expression, prognosis, and methylation\n# Bioinformatic analyses: interaction networks and functional enrichment\n# Experimental validation: knockdown effects in vitro and in vivo\n# Exploratory computational screening and compound prioritization\n# Overall findings and implications","[{\"question\":\"What is the main focus of the study regarding SHCBP1 in COAD?\",\"answer\":\"The study evaluates whether SHCBP1 is upregulated in colon adenocarcinoma and whether it contributes to tumor cell proliferation and tumor growth. It combines database analyses with tissue validation and functional experiments.\"},{\"question\":\"How is SHCBP1 expression linked to patient outcomes in the study?\",\"answer\":\"SHCBP1 is reported as significantly upregulated in COAD and associated with unfavorable prognosis. Promoter hypomethylation is suggested as a contributor to its increased expression.\"},{\"question\":\"What do the in vitro and in vivo functional experiments show after SHCBP1 knockdown?\",\"answer\":\"SHCBP1 knockdown inhibits colon cancer cell proliferation and suppresses tumor growth in vivo. These results support a pro-tumor role for SHCBP1 in COAD.\"}]","SHCBP1 Is Upregulated in Colon Adenocarcinoma and Promotes Tumor Cell Proliferation and Growth | PDF",1790127801,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/114327945249919c3c23ddb6a2520226.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb6affd00d71cb5ca22ce0406cb50254.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/942b2e7021f67afc5e7936fb3c461860.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6404462d05a461c33a760a29f96d205f.webp",980,1385]